Villanueva, Kris Ashly G.

HRN: 13-93-34  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/21/2024
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
03/21/2024
03/27/2024
PO
8ml
BID
PCAP B
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: